The Latest Breaking News from Pfizer

Pfizer Inc is expected to provide around 10 million courses of its highly effective COVID-19 antiviral treatment Paxlovid to low- and middle-income countries this year, according to an official with the Global Fund, a healthcare NGO working to buy the pills from the drugmaker.

Pfizer’s new COVID-19 treatment came with a catch when it debuted late last year: It can take months to make the tablets

Clinical trials of COVID vaccines excluded pregnant people, which left many wondering whether to get vaccinated

Since late 2020, the inequitable access across the globe to COVID-19 vaccines has been a glaring problem. But a remarkable achievement earlier this month offers hope that the supply of vaccines to developing countries will improve: Afrigen Biologics, a South African based company, produced its own version of Moderna’s mRNA…

Strikingly higher rates of decline in effectiveness for younger children suggest the lower dose they receive may be the reason

‘In the Omicron era, the effectiveness against cases of BNT162b2 declined rapidly for children, particularly those 5-11 years,’ a new study says

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 29 strange trades.

Healthcare companies that came up with effective Covid-19 vaccines, treatments and tests are seeing a huge financial payoff and are starting to spend their cash, while grappling with questions about whether the growth is sustainable.

Making sure adults and older children are vaccinated, as well as mask wearing and social distancing, is the best thing to do if worried about under-fives not being eligible, expert says